Sept. 3, 2025
| Today’s news and insights for medtech leaders
The company received FDA authorization to pair its 780G insulin pump with a glucose sensor made by Abbott, and to use the device for Type 2 diabetes.
|
Pulsed field ablation and transcatheter aortic valve implants were in focus at the European Society of Cardiology Congress in Madrid.
|
Analysts said the companies should benefit “as the therapy algorithm is further streamlined and additional patients are encouraged to receive TAVR.”
|
Medical wearable adhesives are key for device success, yet many manufacturers delay adhesive selection. Learn how early wear studies can differentiate your device and ensure market success in
|
Public companies, which accounted for about half of AI-enabled devices on the market, had a higher rate of recalls and a lower rate of clinical evidence, according to a JAMA study.
|
“Larger rounds increasingly favor top-tier companies and AI-native startups, leaving other startups fighting for a smaller pool of capital,” the firm said.
|
From Our Library
Playbook
Custom content for McKesson
|
Playbook
Custom content for Werner
|
View all resources
What We're Reading
KFF Health News
|
NPR
|
Stat
| | 
